sponsored
PatientsVille.com Logo

PatientsVille

Soma Neoplasm Progression Side Effects

Soma Neoplasm Progression Side Effect Reports


The following Soma Neoplasm Progression side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Neoplasm Progression, can occur, and what you can do about them.

A side effect could appear soon after you start Soma or it might take time to develop.



Neoplasm Progression

This Neoplasm Progression side effect was reported by a health professional from NL. A 27-year-old female patient (weight:NA) experienced the following symptoms/conditions: acromegaly. The patient was prescribed Somatuline Autosolution 90mg (dosage: 90 Mg), which was started on Dec 27, 2012. Concurrently used drugs: NA. When starting to take Somatuline Autosolution 90mg the consumer reported the following symptoms:
  • Neoplasm Progression
These side effects may potentially be related to Somatuline Autosolution 90mg.
Neoplasm Progression, Off Label Use

This Neoplasm Progression Somatropin side effect was reported by a physician from FR on Mar 11, 2014. A Female , 13 years of age, was diagnosed with and was treated with Somatropin. The patient presented the following health conditions:
  • Neoplasm Progression
  • Off Label Use
. Somatropin dosage: NA. Additional drugs used at the same time: NA.
Neoplasm Progression

This is a Somatropin side effect report of a 9-year-old female patient (weight:NA) from CA, suffering from the following symptoms/conditions: NA, who was treated with Somatropin (dosage:NA, start time: NS), combined with:
  • Lupron
  • Thyroxine
, and developed a serious reaction and a Neoplasm Progression side effect. The patient presented with:
  • Neoplasm Progression
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Somatropin treatment in female patients suffering from NA, resulting in Neoplasm Progression.

Neoplasm Progression, Neuroendocrine Tumour

A 49-year-old female patient (weight: NA) from IL with the following symptoms: neuroendocrine tumour started Somatuline Sr (lanreotide) (lanreotide Acetate) treatment (dosage: 120 (120 Mg, 1 In 28 )) on 201210. Soon after starting Somatuline Sr (lanreotide) (lanreotide Acetate) treatment, the consumer experienced several side effects, including:
  • Neoplasm Progression
  • Neuroendocrine Tumour
. Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Somatuline Sr (lanreotide) (lanreotide Acetate) side effects, such as Neoplasm Progression.
Neoplasm Progression, Pituitary Tumour Benign

A female patient from FR was prescribed and started Somavert on Jul 02, 2013. Patient felt the following Soma side effects: neoplasm progression, pituitary tumour benign Additional patient health information: Female , 65 years of age, weighting 138.9 lb, The consumer reported the following symptoms: was diagnosed with and. Somavert dosage: 20 Mg, 1x/day. Concurrently used drugs: NA.
Neuroendocrine Tumour, Neoplasm Progression

This report suggests a potential Somatuline Neoplasm Progression side effect(s) that can have serious consequences. A 53-year-old female patient from NL (weight:NA) was diagnosed with the following health condition(s): neuroendocrine tumour and used Somatuline (dosage: 90 Mg (90 Mg, 1 In 14 D), Subcutaneous) starting Jun 07, 2010. Soon after starting Somatuline the patient began experiencing various side effects, including:
  • Neuroendocrine Tumour
  • Neoplasm Progression
Drugs used concurrently:NA. Although Somatuline demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Neoplasm Progression, may still occur.
Constipation, Pneumonia, Vomiting, Hepatic Neoplasm Malignant, Weight Decreased, Malaise, Neoplasm Progression, Nausea

An adverse event was reported by a health professional on May 02, 2012 by a Female taking Somatuline Depot (dosage: NA) . Location: NETHERLANDS , 72 years of age, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Soma side effects: constipation, pneumonia, vomiting, hepatic neoplasm malignant, weight decreased, malaise, neoplasm progression, nausea. Additional medications/treatments:
Associated medications used:
  • Octreotide Acetate
  • Propranolol
The patient was hospitalized.
Weight Decreased, Malaise, Neoplasm Progression, Nausea, Constipation, Hepatic Function Abnormal, Hepatic Neoplasm Malignant, Pneumonia, Vomiting

This Neoplasm Progression problem was reported by a health professional from NETHERLANDS. A 72-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Aug 31, 2010 a consumer started treatment with Somatuline Depot (dosage: NA). The following drugs/medications were being taken at the same time:
  • Propranolol
  • Octreotide Acetate
When commencing Somatuline Depot, the patient experienced the following unwanted symptoms /side effects:
  • Weight Decreased
  • Malaise
  • Neoplasm Progression
  • Nausea
  • Constipation
  • Hepatic Function Abnormal
  • Hepatic Neoplasm Malignant
  • Pneumonia
  • Vomiting
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Neoplasm Progression, may become evident only after a product is in use by the general population.
Neoplasm Progression, Neuroendocrine Tumour

This is a Somatuline Depot side effect report of a 66-year-old female patient (weight: NA) from NETHERLANDS. The patient developed the following symptoms/conditions: NA and was treated with Somatuline Depot (dosage: NA) starting Jun 24, 2011. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Neoplasm Progression
  • Neuroendocrine Tumour
The patient was hospitalized. This opens a possibility that Somatuline Depot could cause Neoplasm Progression and that some female patients may be more susceptible.
Dehydration, Coma, Neoplasm Progression, Hypotension, Colon Cancer Metastatic, Terminal State

This Neoplasm Progression side effect was reported by a consumer or non-health professional from NETHERLANDS on Nov 28, 2011. A female patient from NETHERLANDS , 64 years of age, was diagnosed with and was treated with Somatuline Autosolution 120mg (lanreotide Autogel) (lanreotide) (lanre. Directly after treatment started, patient experienced the unwanted or unexpected Soma side effects: dehydration, coma, neoplasm progression, hypotension, colon cancer metastatic, terminal state. Somatuline Autosolution 120mg (lanreotide Autogel) (lanreotide) (lanre dosage: 120 Mg (120 Mg, 1 In 28 D),intramuscular. The patient was hospitalized. These side effects may potentially be related to Somatuline Autosolution 120mg (lanreotide Autogel) (lanreotide) (lanre.
Craniopharyngioma, Neoplasm Progression

This Neoplasm Progression side effect was reported by a health professional from UNITED KINGDOM. A 45-year-old patient (weight:NA) experienced the following symptoms/conditions: hypopituitarism. The patient was prescribed Somatropin (dosage: 0.2 Mg, 1x/day), which was started on Oct 02, 2006. Concurrently used drugs:
  • Testosterone (1000 Mg, Unk)
  • Ddavp (200 Ug, Unk)
When starting to take Somatropin the consumer reported the following symptoms:
  • Craniopharyngioma
  • Neoplasm Progression
These side effects may potentially be related to Somatropin.
Neoplasm Progression, No Therapeutic Response, Adenoma Benign

This Neoplasm Progression Somatulina Autogel 90mg (lanreotide Autogel) (lanreotide) (lanreotide side effect was reported by a consumer or non-health professional from SPAIN on Oct 25, 2011. A Female , 25 years of age, was diagnosed with and was treated with Somatulina Autogel 90mg (lanreotide Autogel) (lanreotide) (lanreotide. The patient presented the following health conditions:
  • Neoplasm Progression
  • No Therapeutic Response
  • Adenoma Benign
. Somatulina Autogel 90mg (lanreotide Autogel) (lanreotide) (lanreotide dosage: 90 Mg (90 Mg). Additional drugs used at the same time:
  • Somatulina Autogel 60mg (lanreotide Autogel) (lanreotide) (lanreotide (60 Mg (60 Mg,one Cycle))
Neuroendocrine Tumour, Neoplasm Progression, Renal Impairment

This is a Somatuline Depot side effect report of a 63-year-old patient (weight:NA) from NETHERLANDS, suffering from the following symptoms/conditions: neuroendocrine tumour, who was treated with Somatuline Depot (dosage:120 Mg (120 Mg), Intramuscular, start time: Jun 03, 2011), combined with: NA., and developed a serious reaction and a Neoplasm Progression side effect. The patient presented with:
  • Neuroendocrine Tumour
  • Neoplasm Progression
  • Renal Impairment
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Somatuline Depot treatment in patients suffering from neuroendocrine tumour, resulting in Neoplasm Progression.
Neoplasm Progression, Pituitary Cancer Metastatic

A 69-year-old patient (weight: NA) from CANADA with the following symptoms: acromegaly started Somatuline Autogel (lanreotide Autogel) (lanreotide) (lanreotide Aceta treatment (dosage: 120mg (120 Mg, 1 In 28 D), Subcutaneous) on Aug 01, 2010. Soon after starting Somatuline Autogel (lanreotide Autogel) (lanreotide) (lanreotide Aceta treatment, the consumer experienced several side effects, including:
  • Neoplasm Progression
  • Pituitary Cancer Metastatic
. Concurrently used drugs:
  • Synthroid
  • Cortisone (cortisone)
This finding indicates that some patients can be more vulnerable to developing Somatuline Autogel (lanreotide Autogel) (lanreotide) (lanreotide Aceta side effects, such as Neoplasm Progression.
Carcinoid Tumour, Bedridden, Neoplasm Progression

A female patient from NETHERLANDS was prescribed and started Somatuline Depot on May 25, 2011. After Soma was administered, patient encountered several Soma side effects: carcinoid tumour, bedridden, neoplasm progression Additional patient health information: Female , 76 years of age, The consumer reported the following symptoms: was diagnosed with and. Somatuline Depot dosage: 120mg (120 Mg, 1 In 21 D), Intramusuclar. Concurrently used drugs: NA.
Bedridden, Carcinoid Tumour, Neoplasm Progression

This report suggests a potential Somatuline As 120mg (somatuline Sr) (lanreotide) (lanreotide Acetate) Neoplasm Progression side effect(s) that can have serious consequences. A 76-year-old female patient from NETHERLANDS (weight:NA) was diagnosed with the following health condition(s): carcinoid tumour and used Somatuline As 120mg (somatuline Sr) (lanreotide) (lanreotide Acetate) (dosage: 120mg (120 Mg,1 In 21 D),intramuscular) starting Jan 04, 2010. Soon after starting Somatuline As 120mg (somatuline Sr) (lanreotide) (lanreotide Acetate) the patient began experiencing various side effects, including:
  • Bedridden
  • Carcinoid Tumour
  • Neoplasm Progression
Drugs used concurrently:NA. Although Somatuline As 120mg (somatuline Sr) (lanreotide) (lanreotide Acetate) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Neoplasm Progression, may still occur.
Craniopharyngioma, Neoplasm Progression

An adverse event was reported by a physician on Jul 15, 2010 by a Female taking Somatropin (dosage: 1.7 Mg, Qd) was diagnosed with and. Location: UNITED STATES , weighting 140.4 lb, patient began experiencing various side effects, including: Patient felt the following Soma side effects: craniopharyngioma, neoplasm progression. Additional medications/treatments:
Multiple prescriptions taken:
  • Estrogen Patch (50 A?g, Unk)
  • Synthroid (88 A?g, Qd)
  • Progesterone (10 Mg, Unk)
  • Hydrocortisone (20 Mg, Prn)
  • Ddavp (Unk)
Neoplasm Progression

This Neoplasm Progression problem was reported by a health professional from UNITED KINGDOM. A 76-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): hypopituitarism.On NS a consumer started treatment with Somatropin (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Somatropin, the patient experienced the following unwanted symptoms /side effects:
  • Neoplasm Progression
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Neoplasm Progression, may become evident only after a product is in use by the general population.
Neoplasm Progression, Pancreatic Neuroendocrine Tumour

This is a Somatuline Autogel (lanreotide) (lanreotide Acetate) side effect report of a 35-year-old patient (weight: NA) from TURKEY. The patient developed the following symptoms/conditions: pancreatic neuroendocrine tumour and was treated with Somatuline Autogel (lanreotide) (lanreotide Acetate) (dosage: NA) starting Oct 06, 2008. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Neoplasm Progression
  • Pancreatic Neuroendocrine Tumour
This opens a possibility that Somatuline Autogel (lanreotide) (lanreotide Acetate) could cause Neoplasm Progression and that some patients may be more susceptible.
Headache, Laboratory Test Abnormal, Neoplasm Progression

This Neoplasm Progression side effect was reported by a physician from BELGIUM on Nov 17, 2004. A female patient from BELGIUM , 61 years of age, weighting 159.8 lb, was diagnosed with and was treated with Somavert. Patient felt the following Soma side effects: headache, laboratory test abnormal, neoplasm progression. Somavert dosage: See Image. These side effects may potentially be related to Somavert.

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Soma Neoplasm Progression Causes and Reviews


Your thyroid is a butterfly-shaped gland in your neck, just above your collarbone. It makes hormones that help the body work normally. There are several types of cancer of the thyroid gland. You are at greater risk if you

  • Are between ages 25 and 65
  • Are a woman
  • Are Asian
  • Have a family member who has had thyroid disease
  • Have had radiation treatments to your head or neck

You should see a doctor if you have a lump or swelling in your neck. Doctors use a physical exam, thyroid tests, other blood and imaging tests, and a biopsy to diagnose thyroid cancer. Treatment depends on the type of cancer you have and how far the cancer has spread. Many patients receive a combination of treatments. They may include surgery, radioactive iodine, hormone treatment, radiation therapy, chemotherapy, or targeted therapy. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


Soma Neoplasm Progression Reviews

Fri, 24 Feb 2012

My 19 year old son tried to give blood the other day and he was refused because he answered the question that he had taken HGH, Somatropin under a doctor's care.  He asked why and they said it had been shown to cause birth defects.  I am trying to find information on that but I am not being successful.
He took the drugs for about 5 years 12-17.  As we look to the future and him possibly having children is this something we need to be concerned about or aware of?  We are in the process of contacting the doctor who prescribed the meds to get his input.

Tue, 19 Jul 2011

Why do people die after starting Growth Hormone treatment?

Fri, 08 Jul 2011

Sorry about my poor medical english.
I am counselling as a lawyer a young man suffering from liposarcoma, we believe related to Saizen that he received during his childhood.Saizen was the french commercial name for Somatropin.
Has anyone got info on the related risk of cancer?
I would very much appreciate any help to links or info.

Mon, 19 Oct 2009
at what age will be recomended to use HGH for athlete of high level of competence..
Tue, 31 May 2011
I have been on Somatuline Depot since December 2010, I feel like a chemo patient, I have lost my hair, but not lost any weight, will I lose weight, i was 160 in january of last yeat I was 214 since surgery in November. and will I be on the Somatuline for years. is there a recovery for acromegely? I just feel lost right now
Tue, 01 Jun 2010
Somac prescribed for a hyatis hernia. Side effects include: Dizziness, skin itching amp; rash,extreme Sweating, Bloating, gas. Will stop taking medication to see if symptoms persist.
Tue, 11 Jan 2011
I've been on it for 9 months. I weighed at the beginning 125 and had a body fat of 24. I now weigh 130 I have the same body fat percentage. While I have increased muscle mass, I eat well work out, have increased cardio amp; workouts, I'm sad that the only way that I can decrease my body fat is to eat less amp; be hungry always. So of course I can get leaner but cannot stay there. Too painful. It has increased my recovery time from workouts but I'm thinking of going off of it since I am able to control my weight the same as with it or without it.. I am wondering if others do not get leaned out on his product.. I started it because I was so deficient that I had to recover for weeks most time between workouts and had trouble functioning in my. Life. So that is superior now. I thought it would help with fat loss but it does not for me
Sat, 09 Jul 2011
hi i need information toward Somatropin label price?
DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Soma Side Effects

Headache (108)
Death (106)
Nausea (95)
Diarrhoea (90)
Condition Aggravated (77)
Dyspnoea (69)
Vomiting (64)
Pituitary Tumour Benign (62)
Fatigue (61)
Abdominal Pain (59)
Craniopharyngioma (59)
Asthenia (56)
Cholelithiasis (50)
Fall (49)
Neoplasm Recurrence (48)
Injection Site Pain (46)
Arthralgia (46)
Pain (43)
Sleep Apnoea Syndrome (42)
Dizziness (39)
Depression (38)
Weight Increased (38)
Malaise (36)
Chest Pain (36)
Disease Progression (34)
Convulsion (34)
Adenoidal Hypertrophy (33)
Insomnia (33)
Neoplasm Progression (33)
Pyrexia (33)
Pneumonia (32)
Abdominal Pain Upper (31)
Rash (31)
Insulin-like Growth Factor Increased (31)
Meningioma (29)
Tonsillar Hypertrophy (29)
Weight Decreased (27)
Abdominal Distension (27)
Cerebrovascular Accident (26)
Dehydration (26)
Muscle Spasms (26)
Off Label Use (26)
Prostate Cancer (25)
Constipation (24)
Hypertension (23)
Somnolence (23)
Anxiety (22)
Injection Site Nodule (22)
Blood Glucose Increased (22)
Anaemia (21)

➢ More

Discuss Soma Side Effects